Search Bar & Filters
Found 1 Actively Recruiting clinical trials
Actively Recruiting
After thyroid surgery, a small percentage of patients (0.6 to 4%) experience postoperative bleeding, with most bleeding events occurring within the first 48 hours. These complications often progress rapidly and require immediate medical attention, as they can lead to serious outcomes including death in up to 0.6% of cases. Research has shown that continuous pressure increases in the neck area, related to bleeding, can be detected early through invasive pressure measurements. Current routine care relies on patient symptoms and intermittent monitoring, which may delay detection of serious bleeding. This study is evaluating the use of the ISAR-M THYRO device, a diagnostic tool designed to detect haemorrhage early by continuously measuring pressure in the thyroid area after surgery. The device aims to identify increasing cervical pressure caused by hematoma growth before symptoms appear, allowing earlier intervention within 36 to 48 hours post-surgery. Early detection could help guide treatment decisions, such as timing of wound opening, to reduce complications and improve patient safety. Participants will be monitored using the device after thyroid surgery to assess its accuracy in detecting bleeding within 48 hours. The study measures sensitivity and specificity of the device in identifying haemorrhage during this critical postoperative period. By providing objective pressure readings, the study seeks to minimize risks of severe complications like brain damage and death. The trial involves routine clinical follow-up and aims to improve management and outcomes for patients undergoing thyroid surgery.